Hospitals deny having a closed agreement with Novo Nordisk to provide Wegovy through the SUS
Hospitals mentioned by Novo Nordisk have denied any formal agreement to provide the obesity drug Wegovy through Brazil's public health system, the SUS.
Novo Nordisk announces program to offer Wegovy in SUS to treat obesity
Novo Nordisk has launched a program to provide Wegovy for obesity treatment in Brazil's public health system (SUS).
Health Ministry announces R$ 90 million for SUS projects to combat cancer and diabetes
The Brazilian Health Ministry announced a R$ 90 million initiative to fund projects aimed at combating cancer, diabetes, and multiple sclerosis through the public health system (SUS).
See available units for free contraceptive chip application through SUS in Cuiabá
The subdermal contraceptive implant, known as Implanon, is now being offered at 23 Family Health Units in Cuiabá by trained professionals.